Background: Robotic surgery has gained popularity in surgical oncology. Rectal cancer surgery, known to be technically challenging, may benefit from robotics in achieving better mesorectal dissection and may contribute to improved perioperative outcomes. The objective of this study was to compare early experience in robotic surgery to conventional approaches with regard to clinicopathologic and economic parameters.
Methods: A retrospective review using a prospectively maintained database of rectal cancer surgeries performed at a tertiary cancer center from 2007 to 2013 was conducted. These resections included those performed via laparotomy, laparoscopy, and robotic-assisted operations. Perioperative demographic and tumor characteristics were collected, and short-term clinicopathologic outcomes were compared. Additionally, economic variables were evaluated for each patient's episode of care.
Results: Seventy-nine cases were identified. Twenty-six were completed via open approach, 27 laparoscopically, and 26 via robotic assistance. Demographic characteristics were similar between all groups including age, gender, BMI, and Charlson score. Comparison of intraoperative characteristics showed a lower rate of conversion to laparotomy (12 vs. 37%, p = 0.05), and lower estimated blood loss (mean 296 vs. 524 cc, p = 0.04), in the robotic group compared to laparoscopy or open resection. There was no significant difference in quality of total mesorectal excision and number of lymph nodes harvested between the three cohorts. Postoperative complication rate, mean length of stay, 30-day readmission, and 30-day mortality were comparable among the cohorts. Median cost per episode of care was lower in laparoscopic surgery ($11,493), compared to open ($12,558) and robotic approach ($18,273); p = 0.029.
Conclusions: The findings demonstrate similar perioperative and short-term outcomes between robotic surgery and conventional approaches. Robotic assistance is associated with decreased intraoperative blood loss and fewer conversions, albeit at an increased overall cost. Given these benefits, and as data and experience mature, future study is needed to fully define the value of the robotic approach.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00464-015-4390-8 | DOI Listing |
J Gastrointest Cancer
January 2025
Colorectal Research Center, Imam Khomeini Hospital complex, Tehran University of Medical Sciences, Keshavarz Blvd, Tehran, Iran.
Purpose: Carcinoembryonic antigen (CEA) is an important prognostic factor for rectal cancer. This study aims to introduce a novel cutoff point for CEA within the normal range to improve prognosis prediction and enhance patient stratification in rectal cancer patients.
Methods: A total of 316 patients with stages I to III rectal cancer who underwent surgical tumor resection were enrolled.
Cancer Chemother Pharmacol
January 2025
Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
Purpose: Patients with partial or complete DPD deficiency have decreased capacity to degrade fluorouracil and are at risk of developing toxicity, which can be even life-threatening.
Case: A 43-year-old man with moderately differentiated rectal adenocarcinoma on capecitabine presented to the emergency department with complaints of nausea, vomiting, diarrhea, weakness, and lower abdominal pain for several days. Laboratory findings include grade 4 neutropenia (ANC 10) and thrombocytopenia (platelets 36,000).
BMC Surg
January 2025
Department of Gastroenterological Surgery, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-Ku, Osaka, 545-8585, Japan.
Background/aim: The effectiveness of a transanal drainage tube (TAT) for the prevention of anastomotic leakage after double stapling technique (DST) anastomosis in colorectal cancer has been reported. Previously, TATs had been placed and connected to drainage bags. It was considered that a higher decompression effect could be expected by inserting an open-type TAT, without connection to a drainage bag.
View Article and Find Full Text PDFBMC Cancer
January 2025
Department of Surgery, Tokushima University, 3-18-15 Kuramoto-Cho, Tokushima, 770-8503, Japan.
The pro-tumor effects of mast cell (MC) in the tumor microenvironment (TME) are becoming increasingly clear. Recently, MC were shown to contribute to tumor malignancy by supporting the migration of tumor-associated macrophages (TAMs), suggesting a relationship with tumor immunity. In the current study, we aimed to examine the correlation between MC infiltration and neoadjuvant chemoradiotherapy (nCRT) response for locally advanced rectal cancer (LARC).
View Article and Find Full Text PDFJ Appl Clin Med Phys
January 2025
Department of Radiation and Cellular Oncology, University of Chicago Medical Center, Chicago, Illinois, USA.
Background: Various methods exist to correct for intrafraction motion (IFM) of the prostate during radiotherapy. We sought to characterize setup corrections in our practice informed by the TrueBeam Advanced imaging package, and analyze factors associated with IFM.
Methods: 132 men received radiation therapy for prostate cancer with a volumetric modulated arc therapy technique.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!